Skip to content

UEMR vs. CEMR for Diminutive Non-pedunculated Colorectal Polyps

Efficacy and Safety of Underwater vs. Conventional Endoscopic Mucosal Resection for the Treatment of Diminutive Non-pedunculated Colorectal Polyps:A Multicenter Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03833492
Enrollment
130
Registered
2019-02-07
Start date
2019-05-01
Completion date
2019-11-12
Last updated
2019-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Polyps

Brief summary

This clinical trial is being conducted to compare the efficacy and safety of two standard methods of polypectomy,Conventional Endoscopic Mucosal Resection(EMR)and Underwater Endoscopic Mucosal Resection(UEMR),for small colorectal polyps.

Interventions

BEHAVIORALUnderwater EMR

Polypectomy is performed under full water emersion without the use of submucosal injection.

Sponsors

Ningbo No. 1 Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Patients age between 18-75 years old with non-pedunculated colonic polyps (measuring between 4 and 9mm), who willing to participate in this study.

Exclusion criteria

1. pregnancy, 2. inflammatory bowel disease, 3. familial polyposis 4. the use of anticoagulant therapy or antiplatelet therapy 5. the absence of informed patient consent. 6. Polyps showing signs of deep submucosal invasion

Design outcomes

Primary

MeasureTime frameDescription
complete resection rate7 dayscomplete resection rate is defined as a complete en bloc resection of a lesion with tumor-free lateral and vertical margins.
En bloc resection rateimmediatelyEn bloc resection rate was defined as the entire lesion could be removed in 1 piece instead of piecemeal resection.

Secondary

MeasureTime frameDescription
Adverse event rate14 daysIncluding bleeding and perforation , etc.
Procedure time24 hoursTime to execute the program

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026